Edge Pharma

Development and manufacturing of specialty pharmaceutical formulations across various therapeutic categories.

About Edge Pharma

Edge Pharma is a Healthcare company. Development and manufacturing of specialty pharmaceutical formulations across various therapeutic categories. The company has 33 employees. Its Indian entity Edge Pharma Private Limited reported revenue of β‚Ή8.26 Cr. Edge Pharma offers products and services including Specialty Finished Formulations and Research and Development Services. Its focus areas include Pharmaceuticals, Drug Development, Specialty Formulations and Research and Development.

Company details

Edge Pharma was established in 2011 and has been progressed into the field of developing and manufacturing specialty finished formulations. A strong commitment to clients and society is demonstrated by Edge Pharma through the delivery of high-quality products. The company is led by experienced pharmaceutical professionals with a track record of successful project execution from concept to commercialization. Therapeutic categories such as Cardiovascular, CNS, Hematology, Hepatology, Nephrology, Niche Drugs, Oncology, Orphan Drugs, and Urology are covered. Offices are located in Mumbai, India, where operations are conducted efficiently.

  • Employees 33
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Legal Name Edge Pharma Pvt. Ltd.
  • Date of Incorporation 04 Oct, 1989
  • Jurisdiction Mumbai, Maharashtra, India
Key Metrics
  • Indian entity revenue
    ₹8.26 Cr

    FY 2025 · +23% YoY

  • Indian entity net loss
    -₹13.72 Cr

    FY 2025 · -166% margin

  • Indian entity EBITDA
    -₹15.03 Cr

    FY 2025 · -182% margin

  • Employee Count
    33

Products & Services of Edge Pharma

Edge Pharma offers a comprehensive portfolio of products and services, including Specialty Finished Formulations and Research and Development Services.

Specialty Finished Formulations
Pharmaceutical Products

Specialty finished formulations are developed and manufactured for therapeutic categories by Edge Pharma.

Research and Development Services
R&D Services

Research and development services are provided for pharmaceutical projects from concept to commercialization by Edge Pharma.

Board of directors of Edge Pharma Private Limited (Edge Pharma)

Edge Pharma Private Limited is the primary company behind Edge Pharma. The board of Edge Pharma Private Limited currently have 3 directors; the longest-serving is Sameer Madhukar Chandurkar, appointed in 2009. 6 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Sameer Madhukar Chandurkar
DIN 00153235
Director01 Apr 200917 yrs 6 moEdge Pharma Private Limited
Jayshree Sameer Chandurkar
DIN 00153537
Director09 Apr 201412 yrs 6 moEdge Pharma Private Limited
Manish Girishbhai Shah
DIN 09015876
Director17 Feb 20215 yrs 8 moEdge Pharma Private Limited

Financials of Edge Pharma

Figures of Edge Pharma Private Limited, the primary company behind Edge Pharma, for FY 2025. Revenue was ₹8.26 Cr (+23% year on year). Net loss was -₹13.72 Cr (-166% margin). EBITDA was -₹15.03 Cr (-182% margin). Revenue has grown at a compounded annual rate of +18% over three years and -7% over five years.

  • ₹8.26 CrRevenue · FY 2025 · +23% YoY
  • -₹13.72 CrNet loss · -166% margin
  • -₹15.03 CrEBITDA · -182% margin
  • ₹73.10 CrPaid-up capital
  • 33Employees (provident fund records)
  • +18%Revenue CAGR, 3 years
  • -7%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Edge Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for Edge Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Edge Pharma

Edge Pharma has 33 employees.

The primary company behind Edge Pharma, Edge Pharma Private Limited, reported revenue of β‚Ή8.26 Cr for FY 2025, up 23% year on year.

Edge Pharma was established in 2011 and has been progressed into the field of developing and manufacturing specialty finished formulations. A strong commitment to clients and society is demonstrated by Edge Pharma through the delivery of high-quality products. The company is led by experienced pharmaceutical professionals with a track record of successful project execution from concept to commercialization. Therapeutic categories such as Cardiovascular, CNS, Hematology, Hepatology, Nephrology, Niche Drugs, Oncology, Orphan Drugs, and Urology are covered. Offices are located in Mumbai, India, where operations are conducted efficiently.

Edge Pharma offers Specialty Finished Formulations and Research and Development Services.

Edge Pharma operates through Edge Pharma Private Limited.

The legal entities of Edge Pharma currently have 4 directors, including Sameer Madhukar Chandurkar, Manish Girishbhai Shah, Jayshree Sameer Chandurkar and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available